Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Micelles01:30

Micelles

364
Micelle formation is an intricate process that hinges on the properties of amphiphilic or amphipathic molecules and the conditions of the system in which they are found. Amphiphilic molecules, which have both hydrophilic (water-attracting) and hydrophobic (water-repelling) parts, play a critical role in this process.In aqueous environments, these molecules arrange themselves such that their hydrophilic heads are turned towards the water phase, while their hydrophobic tails are oriented away...
364
Drug Delivery Systems: Different Types01:27

Drug Delivery Systems: Different Types

406
Conventional oral drug products, termed immediate-release (IR) formulations, are engineered to promptly release their active pharmaceutical ingredient (API) upon ingestion, typically in tablets or capsules. This rapid release often results in swift drug absorption and consequent pharmacodynamic effects, although the timing and intensity can vary depending on the drug's properties. Prodrugs within these formulations require metabolic conversion to activate their pharmacodynamic effects,...
406
Modified-Release Drug Delivery Systems: Classification01:23

Modified-Release Drug Delivery Systems: Classification

315
Modified-release drug delivery systems improve drug efficacy and minimize side effects by controlling the rate and location of drug release. These systems fall into three categories: rate-programmed, stimuli-activated, and site-targeted.Rate-programmed systems release drugs at a predetermined rate, maintaining consistent therapeutic levels and reducing fluctuations that could lead to toxicity or subtherapeutic effects. These systems use polymeric matrices, reservoir-based designs, or osmotic...
315
Modified-Release Drug Delivery Systems: Stimuli-Activated01:30

Modified-Release Drug Delivery Systems: Stimuli-Activated

177
Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also...
177
Modified-Release Drug Delivery Systems: Site-Targeted01:24

Modified-Release Drug Delivery Systems: Site-Targeted

164
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
164
Site-Targeted Drug Delivery Systems: Polymeric Carriers01:24

Site-Targeted Drug Delivery Systems: Polymeric Carriers

160
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
160

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

SOCS5 suppresses antitumor immunity in colorectal cancer by promoting IFNAR1 ubiquitylation and type I interferon response.

Biochimica et biophysica acta. Molecular basis of disease·2026
Same author

Clinical outcomes of repeat peroral endoscopic myotomy for recurrent esophageal achalasia: A case series.

Medicine·2026
Same author

NEDD4L suppresses colorectal cancer metastasis and immune escape by inhibiting STAT3 signaling.

Tissue & cell·2026
Same author

Time-resolved multi-omics reveals molecular dynamics of Synechocystis sp. PCC 6803 to cadmium stress.

Environmental pollution (Barking, Essex : 1987)·2026
Same author

Nuclear-Targeted Drug Delivery Systems for Cancer Therapy: Advances, and Challenges.

Molecules (Basel, Switzerland)·2026
Same author

Temperature modulates the dissolved organic matter‑mediated triplet and singlet oxygen formation: Implications for ractopamine photodegradation.

Ecotoxicology and environmental safety·2026

Related Experiment Video

Updated: May 4, 2026

Preparation and Characterization of Individual and Multi-drug Loaded Physically Entrapped Polymeric Micelles
07:32

Preparation and Characterization of Individual and Multi-drug Loaded Physically Entrapped Polymeric Micelles

Published on: August 28, 2015

11.3K

Enzyme-Responsive Micelles with High Drug-Loading Capacity for Antitumor Therapy.

Dong Wan1,2, Yanan Wu1, Yuying Zhang2

  • 1School of Chemistry, Tiangong University, Tianjin, 300387, China.

Macromolecular Rapid Communications
|August 30, 2024
PubMed
Summary

This study developed a novel drug delivery system with high drug-loading capacity for enhanced tumor targeting. The system effectively delivers chemotherapy drugs, improving therapeutic effects and showing great potential for clinical cancer treatment.

Keywords:
cancerdrug deliverydrug‐loadingenzyme responsetherapy

More Related Videos

Preparation and Characterization of Lipophilic Doxorubicin Pro-drug Micelles
09:56

Preparation and Characterization of Lipophilic Doxorubicin Pro-drug Micelles

Published on: August 2, 2016

14.9K
A Facile and Efficient Approach for the Production of Reversible Disulfide Cross-linked Micelles
09:57

A Facile and Efficient Approach for the Production of Reversible Disulfide Cross-linked Micelles

Published on: December 23, 2016

8.8K

Related Experiment Videos

Last Updated: May 4, 2026

Preparation and Characterization of Individual and Multi-drug Loaded Physically Entrapped Polymeric Micelles
07:32

Preparation and Characterization of Individual and Multi-drug Loaded Physically Entrapped Polymeric Micelles

Published on: August 28, 2015

11.3K
Preparation and Characterization of Lipophilic Doxorubicin Pro-drug Micelles
09:56

Preparation and Characterization of Lipophilic Doxorubicin Pro-drug Micelles

Published on: August 2, 2016

14.9K
A Facile and Efficient Approach for the Production of Reversible Disulfide Cross-linked Micelles
09:57

A Facile and Efficient Approach for the Production of Reversible Disulfide Cross-linked Micelles

Published on: December 23, 2016

8.8K

Area of Science:

  • Biomedical Engineering
  • Nanotechnology
  • Oncology

Background:

  • Conventional chemotherapy faces challenges with poor drug targeting and low drug-loading capacity.
  • Novel drug delivery systems are needed to improve therapeutic efficacy and reduce side effects.

Purpose of the Study:

  • To develop a high drug-loading copolymer for enhanced chemotherapy delivery.
  • To investigate the targeted delivery and synergistic therapeutic effect of the novel system in tumors.

Main Methods:

  • Synthesis of a high drug-loaded mPEG-GFLGDDD-DOX copolymer via amide reaction.
  • Utilizing the enhanced permeability and retention (EPR) effect for tumor tissue enrichment.
  • Employing cathepsin B-sensitive peptide (GFLG) for triggered drug release within tumor cells.

Main Results:

  • The mPEG-GFLGDDD-DOX copolymer demonstrated high drug-loading capacity.
  • PEGylation prolonged blood circulation time and facilitated tumor accumulation via the EPR effect.
  • The GFLG peptide linker enabled cathepsin B-mediated cleavage, leading to enhanced tumor cell uptake.
  • Synergistic action of released DOX resulted in effective tumor cell killing and enhanced therapeutic outcomes.

Conclusions:

  • The developed high drug-loading delivery system shows significant potential for improved tumor targeting and treatment.
  • This novel approach offers a promising strategy for overcoming limitations of conventional chemotherapy.